Hua Medicine (Shanghai) Ltd. (HKG:2552)
Hong Kong · Delayed Price · Currency is HKD 2.230
-0.060 (-2.62%)
Oct 9, 2026, 4:08 PM HKT
Hua Medicine (Shanghai) Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Hua Medicine (Shanghai) stock has a consensus rating of "Strong Buy" and an average price target of $4.52. The average 1-year stock price forecast is 102.69% higher than the current stock price, while the lowest is $3.52 (+57.85%) and the highest is $5.52 (+147.53%).
Price Target: $4.52 (+102.69%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Hua Medicine (Shanghai) stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Jan '26 | Apr '26 | May '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 1 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Guoyuan Securities (HK) No rating | Guoyuan Securities (HK) | Buy Maintains $3.52 | Buy | Maintains | $3.52 | +57.85% | Sep 22, 2026 |
Financial Forecast
Revenue This Year
912.00M
from 492.93M
Increased by 85.01%
Revenue Next Year
1.36B
from 912.00M
Increased by 49.01%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is CNY.